Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
Treadwell Therapeutics’ CFI-402257 Granted Fast-Track Status by FDA
January 25, 2025
Policy / Regulatory
CDE Releases 66th Batch of Chemical Generic Reference Preparations
January 25, 2025
Company
Drug
Jiangsu Kanion’s KYS202002A Greenlit for Clinical Study in Multiple Myeloma
January 25, 2025
Company
Deals
Gaoling Medical Secures Funding for Infrared Thermotherapy Technology
January 25, 2025
Company
Drug
Yiling Pharmaceutical’s BIO-008 Accepted for Review by China’s NMPA
January 25, 2025
Company
Deals
Sino Biopharmaceutical Secures Rights to Biosimilar of Amgen’s Xgeva in China
January 25, 2025
Company
Deals
CanSino Biologics to Issue GDRs on SWX Swiss Exchange to Boost Globalization
January 25, 2025
Company
Drug
Luye Pharma Launches Named Patient Program for Lurbinectedin in Hong Kong
January 25, 2025
Company
Drug
Innovent Biologics Doses First Patient in Phase III Study for Mazdutide
January 25, 2025
Policy / Regulatory
China Meheco Keyi Pharma’s Ganciclovir Loses VBP Bid After Inspection Failure
February 2, 2025
Policy / Regulatory
NMPA Releases 63rd Batch of Reference Drugs for Generic Quality Evaluation
January 25, 2025
Company
Drug
Cosunter’s COVID-19 Drug GST-HG171 Shows Superior Efficacy in Trial
January 25, 2025
1
2
…
1,052
1,053
1,054
1,055
1,056
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?